Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Study Completion Date

February 28, 2006

Conditions
Endometrial Cancer
Interventions
DRUG

alvocidib

Trial Locations (54)

1450

Australia New Zealand Gynaecological Oncology Trials Group, Camperdown

10021

Memorial Sloan-Kettering Cancer Center, New York

11030

North Shore University Hospital, Manhasset

11203

State University of New York Health Science Center at Brooklyn, Brooklyn

19111

Fox Chase Cancer Center, Philadelphia

22908

Cancer Center at the University of Virginia, Charlottesville

27710

Duke Comprehensive Cancer Center, Durham

37203

Brookview Research, Inc., Nashville

44106

Ireland Cancer Center, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

55455

University of Minnesota Cancer Center, Minneapolis

63110

Washington University School of Medicine, St Louis

65203

Ellis Fischel Cancer Center - Columbia, Columbia

73190

University of Oklahoma College of Medicine, Oklahoma City

80010

University of Colorado Cancer Center, Denver

92868

Chao Family Comprehensive Cancer Center, Orange

95032

Community Hospital of Los Gatos, Los Gatos

98405

Tacoma General Hospital, Tacoma

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

20307-5001

Walter Reed Army Medical Center, Washington D.C.

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

60612-3864

Rush-Presbyterian-St. Luke's Medical Center, Chicago

60637-1470

University of Chicago Cancer Research Center, Chicago

46202-5289

Indiana University Cancer Center, Indianapolis

52242-1009

Holden Comprehensive Cancer Center, Iowa City

40536-0084

Albert B. Chandler Medical Center, University of Kentucky, Lexington

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

02111

Tuft-New England Medical Center, Boston

01605-2982

University of Massachusetts Memorial Medical Center - University Campus, Worcester

55905-0001

Mayo Clinic Cancer Center, Rochester

39216-4505

University of Mississippi Medical Center, Jackson

39534-2576

Keesler Medical Center - Keesler AFB, Keesler Air Force Base

08103-1489

Cooper Hospital/University Medical Center, Camden

14263-0001

Roswell Park Cancer Institute, Buffalo

11794-8091

State University of New York Health Sciences Center - Stony Brook, Stony Brook

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27157-1065

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

45267-0526

Barrett Cancer Center, Cincinnati

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

19001-3788

Abington Memorial Hospital, Abington

17033-0850

Milton S. Hershey Medical Center, Hershey

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

19107-5541

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

29425-2233

Medical University of South Carolina, Charleston

75390-9032

Simmons Cancer Center - Dallas, Dallas

77555-0587

University of Texas Medical Branch, Galveston

77030-4009

CCOP - M.D. Anderson Research Base, Houston

University of Texas - MD Anderson Cancer Center, Houston

05401

Fletcher Allen Health Care - Medical Center Campus, Burlington

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

N-0310

Norwegian Radium Hospital, Oslo

B15 2TT

University of Birmingham, Birmingham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00023894 - Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer | Biotech Hunter | Biotech Hunter